Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07186842
What this trial is testing

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Who this might be right for
Advanced Solid Cancers
BioNTech SE 245
Early research (Phase 1)Not Yet RecruitingNCT07664397
What this trial is testing

Imaging Study of [89Zr]DFO-YS5 for Cancer Detection

Who this might be right for
Bladder CancerNerve Sheath TumorNerve Sheath Tumors+9 more
Robert Flavell, MD, PhD 40
Not applicableUnknownNCT02496442
What this trial is testing

Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan

Who this might be right for
Prostatic HyperplasiaKidney CalculiBladder Tumors
Flowmed 30
Not applicableLooking for participantsNCT04993859
What this trial is testing

Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children

Who this might be right for
Survivors of Childhood CancerBladder Dysfunction
University of Colorado, Denver 152
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Not applicableLooking for participantsNCT06421142
What this trial is testing

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasms
First Affiliated Hospital of Fujian Medical University 80
Testing effectiveness (Phase 2)Looking for participantsNCT03866382
What this trial is testing

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Who this might be right for
Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more
National Cancer Institute (NCI) 314
Testing effectiveness (Phase 2)UnknownNCT01196403
What this trial is testing

Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Wales Cancer Trials Unit 92
Not applicableStudy completedNCT04229862
What this trial is testing

Effect of Head Elevation on LMA Insertion

Who this might be right for
Laryngeal MasksUrinary Bladder Neoplasms
Asan Medical Center 110
Not applicableStudy completedNCT03434132
What this trial is testing

Open Versus Robot Assisted Radical Cystectomy With Totally Intracorporeal Urinary Diversion.

Who this might be right for
Bladder Cancer
Regina Elena Cancer Institute 116
Not applicableActive Not RecruitingNCT05219734
What this trial is testing

MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment

Who this might be right for
CancerSolid TumorNon Small Cell Lung Cancer+2 more
Invitae Corporation 400
Testing effectiveness (Phase 2)Looking for participantsNCT06161532
What this trial is testing

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Who this might be right for
Small Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT04134104
What this trial is testing

Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy

Who this might be right for
Bowel DysfunctionBladder DysfunctionSexual Dysfunction+1 more
National Academy of Medical Sciences, Nepal 38
Large-scale testing (Phase 3)Study completedNCT00330499
What this trial is testing

Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.

Who this might be right for
Transitional Cell Carcinoma of Urinary Bladder
Trans Tasman Radiation Oncology Group 67
Large-scale testing (Phase 3)Study completedNCT02603432
What this trial is testing

Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)

Who this might be right for
Urothelial Cancer
Pfizer 700
Not applicableActive Not RecruitingNCT06307704
What this trial is testing

Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients

Who this might be right for
Prostate CancerUrinary Bladder CancerSurgery+2 more
Nazmy Edward Seif 88
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07100184
What this trial is testing

RC48 in Combination With Radiotherapy for HER2-Expressing NMIBC Patients

Who this might be right for
HER2-expressing High-risk or Very High-risk NMIBC Without Visible Foci of Disease After TURBT
Peking University First Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04718584
What this trial is testing

The Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors

Who this might be right for
Bladder CancerRenal CarcinomaAdvanced Penile Carcinoma
Dragonboat Biopharmaceutical Company Limited 27
Not applicableStudy completedNCT02452944
What this trial is testing

Comparison of Nerve Stimulating Approach and Interfascial Injection Approach During Sono-guided Obturator Nerve Block

Who this might be right for
Bladder Cancer
Gachon University Gil Medical Center 62
Large-scale testing (Phase 3)Study completedNCT00625664
What this trial is testing

Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasms
Sanofi 337
Next Page
60